Tweet
Is Autologous Hematopoietic Stem Cell Transplantation Still Viable for MS?
FitzGerald, Susan
Neurology Today: 18 May 2017 - Volume 17 - Issue 10 - p 10–13
doi: 10.1097/01.NT.0000520472.01901.8f
ARTICLE IN BRIEF
Two new reports on autologous hematopoietic stem cell transplantation (AHSCT) for multiple sclerosis (MS) indicate that the therapy may benefit some MS patients. But whether AHSCT is viable is a matter of debate among some MS experts, who contend that the regimen could be toxic, leading to infection and death.
FULL ARTICLE: http://journals.lww.com/neurotodayon...em_Cell.6.aspx
FitzGerald, Susan
Neurology Today: 18 May 2017 - Volume 17 - Issue 10 - p 10–13
doi: 10.1097/01.NT.0000520472.01901.8f
ARTICLE IN BRIEF
Two new reports on autologous hematopoietic stem cell transplantation (AHSCT) for multiple sclerosis (MS) indicate that the therapy may benefit some MS patients. But whether AHSCT is viable is a matter of debate among some MS experts, who contend that the regimen could be toxic, leading to infection and death.
FULL ARTICLE: http://journals.lww.com/neurotodayon...em_Cell.6.aspx